1-5 of 5
Thomas J. Cramer, PhD
Close
Sort by
Journal Articles

Vascular Remodeling Underlies Re-Bleeding in Hemophilic Arthropathy

Annette Von Drygalski, MD PharmD, Vikas Bhat, PhD, Merissa Olmer, MS, Shweta Joshi, PhD, Donald Durden, MD, Thomas J Cramer, PhD, Richard FW Barnes, PhD MPH, Scott T Ball, MD, Tudor H Hughes, MD, Mauricio Silva, MD, James V Luck, MD, Randy Moore, DC,RDMS, Laurent O. Mosnier, PhD
Journal: Blood
Blood (2015) 126 (23): 1038.
https://doi.org/10.1182/blood.V126.23.1038.1038
Published: 2015
Journal Articles

The Hypertension of Hemophilia Is Associated with Vascular Joint Remodeling and Cannot be Explained By the Usual Cardiovascular Risk Factors

Richard FW Barnes, PhD MPH, Thomas J Cramer, PhD, Afrah S Sait, MD, Rebecca Kruse-Jarres, MD MPH, Doris V. Quon, MD PhD, Annette von Drygalski, MD PharmD
Journal: Blood
Blood (2015) 126 (23): 762.
https://doi.org/10.1182/blood.V126.23.762.762
Published: 2015
Journal Articles

Reduction Of Histone H1 Cytotoxicity By Activated Protein C and Its Exosite Variants

Thomas J. Cramer, PhD, Ranjeet K. Sinha, PhD, John H. Griffin, PhD
Journal: Blood
Blood (2013) 122 (21): 2334.
https://doi.org/10.1182/blood.V122.21.2334.2334
Published: 2013
Journal Articles

An Engineered Factor Fva Prevents Bleeding Induced By Anticoagulant Wild Type Activated Protein C

Annette Von Drygalski, MD, PharmD, Andrew J. Gale, PhD, Laurent Burnier, PhD, Thomas J. Cramer, PhD, John H. Griffin, PhD, Laurent O. Mosnier, PhD
Journal: Blood
Blood (2013) 122 (21): 203.
https://doi.org/10.1182/blood.V122.21.203.203
Published: 2013
Journal Articles

Superior in Vivo Hemostatic Properties of an Engineered Factor Va Variant for Hemophilia Mice

Annette Von Drygalski, MD, PharmD, Thomas J. Cramer, PhD, John H. Griffin, PhD, Andrew J. Gale, PhD, Laurent O. Mosnier, PhD
Journal: Blood
Blood (2012) 120 (21): 17.
https://doi.org/10.1182/blood.V120.21.17.17
Published: 2012